Reply to: "Investigation of Disease Modifying Mechanisms in CSF1R-Related Leukoencephalopathy"

Affiliations

¹ Department of Neurology, Mayo Clinic, Rochester, Minnesota, USA.
² Department of Developmental and Molecular Biology, Albert Einstein College of Medicine, Bronx, New York, USA.
³ Department of Neurology, Mayo Clinic, Jacksonville, Florida, USA.

Comment

Philip W Tipton et al. Mov Disord. 2021 Jun.

. 2021 Jun;36(6):1471.

doi: 10.1002/mds.28626.

¹ Department of Neurology, Mayo Clinic, Rochester, Minnesota, USA.
² Department of Developmental and Molecular Biology, Albert Einstein College of Medicine, Bronx, New York, USA.
³ Department of Neurology, Mayo Clinic, Jacksonville, Florida, USA.

No abstract available

Keywords: CSF1R-related leukoencephalopathy; corticosteroid; microglia.

Comment on

Is Pre-Symptomatic Immunosuppression Protective in CSF1R-Related Leukoencephalopathy?
Tipton PW, Stanley ER, Chitu V, Wszolek ZK. Tipton PW, et al. Mov Disord. 2021 Apr;36(4):852-856. doi: 10.1002/mds.28515. Epub 2021 Feb 15. Mov Disord. 2021. PMID: 33590562 Free PMC article. No abstract available.
Chronic Immunosuppression and Potential Infection Risks in CSF1R-Related Leukoencephalopathy.
Han J, Harris RA, Karrenbauer VD. Han J, et al. Mov Disord. 2021 Jun;36(6):1470-1471. doi: 10.1002/mds.28627. Mov Disord. 2021. PMID: 34145638 No abstract available.